FDA Approves LURASIDONE HYDROCHLORIDE — Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Inc.

Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Inc. announced FDA approval for its generic LURASIDONE HYDROCHLORIDE tablets, expanding the supply chain for this schizophrenia treatment. The company expects the launch to intensify competition in the antipsychotic market, potentially driving down costs for payers and patients.